An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease

Neurobiology of Aging

Volumn 34, Issue 5, 2013, Pages 1519.e13-1519.e17

  Liu, Qiu Yan ^a   Yu, Jin Tai ^a   Miao, Dan ^a   Ma, Xiao Ying ^a   Wang, Hui Fu ^a   Wang, Wei ^a   Tan, Lan ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alzheimer's disease; EIF2AK3; MAPT; MOBP; Polymorphisms; Progressive supranuclear palsy

Indexed keywords

APOLIPOPROTEIN E4;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 3 GENE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELIN OLIGODENDROCYTE ASSOCIATED BASIC PROTEIN GENE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYNTAXIN6 GENE;

EID: 84873477565     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.10.004     Document Type: Article

References (39)

1. Abraham R., Sims R., Carroll L., Hollingworth P., O'Donovan M.C., Williams J., Owen M.J. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150:1152-1155.
2. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 1999, 8:711-715.
3. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell. Biol. 1985, 101:1371-1378.
4. Bullido M.J., Aldudo J., Frank A., Coria F., Avila J., Valdivieso F. A polymorphism in the tau gene associated with risk for Alzheimer 's disease. Neurosci. Lett. 2000, 278:49-52.
5. Cleveland D.W., Hwo S.Y., Kirschner M.W. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 1977, 116:227-247.
6. Couchie D., Mavilia C., Georgieff I.S., Liem R.K., Shelanski M.L., Nunez J. Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:4378-4381.
7. Crespo-Biel N., Theunis C., Van Leuven F. Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease. Int. J. Alzheimers Dis. 2012, 2012:251426.
8. Crozier R., Valpreda K., Reinhart P., Bowlby M., Bard J. Age-related synaptic dysfunctionin atauopathy mouse model (PrP-MAPT) of Alzheimer's disease. Alzheimers Dement. 2008, 4:422-423.
9. Dickson D.W. Neuropathology of Alzheimer's disease and other dementias. Clin. Geriatr. Med. 2001, 17:209-228.
10. Evans W., Fung H.C., Steele J., Eerola J., Tienari P., Pittman A., Silva R., Myers A., Vrieze F.W., Singleton A., Hardy J. The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci. Lett. 2004, 369:183-185.
11. Favis R., Day J.P., Gerry N.P., Phelan C., Narod S., Barany F. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat. Biotechnol. 2000, 18:561-564.
12. Hardy J., Pittman A., Myers A., Gwinn-Hardy K., Fung H.C., deSilva R., Hutton M., Duckworth J. Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens. Biochem. Soc. Trans. 2005, 33:582-585.
13. Höglinger G.U., Melhem N.M., Dickson D.W., Sleiman P.M., Wang L.S., Klei L., Rademakers R., de Silva R., Litvan I., Riley D.E., van Swieten J.C., Heutink P., Wszolek Z.K., Uitti R.J., Vandrovcova J., Hurtig H.I., Gross R.G., Maetzler W., Goldwurm S., Tolosa E., Borroni B., Pastor P., PSP Genetics Study Group, Cantwell L.B., Han M.R., Dillman A., van der Brug M.P., Gibbs J.R., Cookson M.R., Hernandez D.G., Singleton A.B., Farrer M.J., Yu C.E., Golbe L.I., Revesz T., Hardy J., Lees A.J., Devlin B., Hakonarson H., Müller U., Schellenberg G.D. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 2011, 43:699-705.
14. Hoozemans J.J., van Haastert E.S., Nijholt D.A., Rozemuller A.J., Eikelenboom P., Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 2009, 174:1241-1251.
15. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell. Biol. 2006, 7:631-643.
16. Kwok J.B., Hallupp M., Loy C.T., Chan D.K., Woo J., Mellick G.D., Buchanan D.D., Silburn P.A., Halliday G.M., Schofield P.R. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann. Neurol. 2005, 58:829-839.
17. Kwon J.M., Nowotny P., Shah P.K., Chakraverty S., Norton J., Morris J.C., Goate A.M. Tau polymorphisms are not associated with Alzheimer's disease. Neurosci. Lett. 2000, 284:77-80.
18. Laws S.M., Fredrich P., Diehl-Schmid J., Müller J., Eisele T., Bäuml J., Förstl H., Kurz A., Riemenschneider M. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol. Psychiatry 2007, 12:510-517.
19. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
20. Montague P., McCallion A.S., Davies R.W., Griffiths I.R. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev. Neurosci. 2006, 28:479-487.
21. Mukherjee O., Kauwe J.S., Mayo K., Morris J.C., Goate A.M. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer 's disease. BMC Genet. 2007, 8:3.
22. Myers A.J., Kaleem M., Marlowe L., Pittman A.M., Lees A.J., Fung H.C., Duckworth J., Leung D., Gibson A., Morris C.M., de Silva R., Hardy J. The H1c haplotype at the MAPT locus is associated with Alzheimer 's disease. Hum. Mol. Genet. 2005, 14:2399-2404.
23. Myers A.J., Pittman A.M., Zhao A.S., Rohrer K., Kaleem M., Marlowe L., Lees A., Leung D., McKeith I.G., Perry R.H., Morris C.M., Trojanowski J.Q., Clark C., Karlawish J., Arnold S., Forman M.S., Van Deerlin V., de Silva R., Hardy J. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 2007, 25:561-570.
24. Pastor P., Roe C.M., Villegas A., Bedoya G., Chakraverty S., García G., Tirado V., Norton J., Ríos S., Martínez M., Kosik K.S., Lopera F., Goate A.M. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann. Neurol. 2003, 54:163-169.
25. Pittman A.M., Myers A.J., Abou-Sleiman P., Fung H.C., Kaleem M., Marlowe L., Duckworth J., Leung D., Williams D., Kilford L., Thomas N., Morris C.M., Dickson D., Wood N.W., Hardy J., Lees A.J., de Silva R. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 2005, 42:837-846.
26. Pittman A.M., Myers A.J., Duckworth J., Bryden L., Hanson M., Abou-Sleiman P., Wood N.W., Hardy J., Lees A., de Silva R. The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet. 2004, 13:1267-1274.
27. Rademakers R., Melquist S., Cruts M., Theuns J., Del-Favero J., Poorkaj P., Baker M., Sleegers K., Crook R., De Pooter T., Bel Kacem S., Adamson J., Van den Bossche D., Van den Broeck M., Gass J., Corsmit E., De Rijk P., Thomas N., Engelborghs S., Heckman M., Litvan I., Crook J., De Deyn P.P., Dickson D., Schellenberg G.D., Van Broeckhoven C., Hutton M.L. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 2005, 14:3281-3292.
28. Skipper L., Wilkes K., Toft M., Baker M., Lincoln S., Hulihan M., Ross O.A., Hutton M., Aasly J., Farrer M. Linkage disequilibrium and association of MAPT H1 in Parkinson Disease. Am. J. Hum. Genet. 2004, 75:669-677.
29. St.George-Hyslop P., McLachlan D.C., Tsuda T., Rogaev E., Karlinsky H., Lippa C.F., Pollen D. Alzheimer's disease and possible gene interaction. Science 1994, 263:537.
30. Sun W.J., Jia J.P. The + 347C promoter allele up-regulates MAPT expression and is associated with Alzheimer's disease among the Chinese Han. Neurosci. Lett. 2009, 450:340-343.
31. Unterberger U., Höftberger R., Gelpi E., Flicker H., Budka H., Voigtländer T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 2006, 65:348-357.
32. Waldemar G., Dubois B., Emre M., Georges J., McKeith I.G., Rossor M., Scheltens P., Tariska P., Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur. J. Neurol. 2007, 14:e1-e26.
33. Wang J.Z., Grundke-Iqbal I., Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 2007, 25:59-68.
34. Wendler F., Tooze S. Syntaxin 6: the promiscuous behaviour of a SNARE protein. Traffic 2001, 2:606-611.
35. Wijsman E.M., Daw E.W., Yu X., Steinbart E.J., Nochlin D., Bird T.D., Schellenberg G.D. APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 132:14-20.
36. Xiao Z., Xiao J., Jiang Y., Zhang S., Yu M., Zhao J., Wei D., Cao H. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol. Res. 2006, 34:150-155.
37. Yasojima K., McGeer E.G., McGeer P.L. Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA. Brain Res. 1999, 831:301-305.
38. Zhang N., Yu J.T., Yang Y., Yang J., Zhang W., Tan L. Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese. Brain Res. 2011, 1391:147-153.
39. Zou F., Chai H.S., Younkin C.S., Allen M., Crook J., Pankratz V.S., Carrasquillo M.M., Rowley C.N., Nair A.A., Middha S., Maharjan S., Nguyen T., Ma L., Malphrus K.G., Palusak R., Lincoln S., Bisceglio G., Georgescu C., Kouri N., Kolbert C.P., Jen J., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D., Alzheimer's Disease Genetics Consortium, Petersen R.C., Graff-Radford N.R., Dickson D.W., Younkin S.G., Ertekin-Taner N. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 2012, 8:e1002707.